Literature DB >> 1331348

Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile.

R Sawaya1, M Zuccarello, M Elkalliny, H Nishiyama.   

Abstract

Forty-six patients who underwent surgery for brain tumors were studied prospectively with 125I labeled Fibrinogen leg scans to detect postoperative venous thrombosis. The incidence of thrombosis was 72% for meningioma patients, 60% for glioblastoma patients, and 20% for brain metastasis patients. Correlation between the occurrence of venous thrombosis and the various clinical factors thought to be responsible for the high incidence of thrombosis generally failed to show statistical significance. This finding, along with the marked variation in the incidence of venous thrombosis between the different brain tumor groups, strongly suggests that biological factors play a more important role than clinical factors in determining which brain tumor patient will suffer a postoperative thrombotic event.

Entities:  

Mesh:

Year:  1992        PMID: 1331348     DOI: 10.1007/bf00177615

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Pulmonary embolism as a cause of death in the neurosurgical patient.

Authors:  N WETZEL; M C ANDERSON; T W SHIELDS
Journal:  J Neurosurg       Date:  1960-07       Impact factor: 5.115

2.  Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome.

Authors:  H E Sjöberg; M Blombäck; P O Granberg
Journal:  Acta Med Scand       Date:  1976

3.  Safety of mini-dose heparin administration for neurosurgical patients.

Authors:  H G Barnett; J R Clifford; R C Llewellyn
Journal:  J Neurosurg       Date:  1977-07       Impact factor: 5.115

4.  Effects of external pneumatic intermittent compression on fibrinolysis in man.

Authors:  F Allenby; L Boardman; J J Pflug; J S Calnan
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

5.  Thromboembolism and brain tumors.

Authors:  R Brisman; J Mendell
Journal:  J Neurosurg       Date:  1973-03       Impact factor: 5.115

6.  Incidence of lower extremity deep vein thrombosis in neurosurgical patients.

Authors:  J B Valladares; J Hankinson
Journal:  Neurosurgery       Date:  1980-02       Impact factor: 4.654

7.  The incidence of systemic venous thrombosis and the risk of anticoagulation in patients with malignant gliomas.

Authors:  R L Ruff; J B Posner
Journal:  Trans Am Neurol Assoc       Date:  1981

8.  Preoperative prediction of postoperative deep vein thrombosis.

Authors:  J K Clayton; J A Anderson; G P McNicol
Journal:  Br Med J       Date:  1976-10-16

9.  Prophylaxis of thromboembolism in the neurosurgical patient: a review.

Authors:  S K Powers; M S Edwards
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

10.  Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism.

Authors:  A K Choucair; P Silver; V A Levin
Journal:  J Neurosurg       Date:  1987-03       Impact factor: 5.115

View more
  26 in total

1.  Are readmission rates on a neurosurgical service indicators of quality of care?

Authors:  Manish N Shah; Ivan T Stoev; Dominic E Sanford; Feng Gao; Paul Santiago; David P Jaques; Ralph G Dacey
Journal:  J Neurosurg       Date:  2013-04-26       Impact factor: 5.115

Review 2.  Medical management of patients with brain tumors.

Authors:  Patrick Y Wen; David Schiff; Santosh Kesari; Jan Drappatz; Debra C Gigas; Lisa Doherty
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

3.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

Review 4.  Symptomatic management and imaging of brain metastases.

Authors:  Evert C A Kaal; Martin J B Taphoorn; Charles J Vecht
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

5.  A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.

Authors:  Michael B Streiff; Xiaobu Ye; Thomas S Kickler; Serena Desideri; Jayesh Jani; Joy Fisher; Stuart A Grossman
Journal:  J Neurooncol       Date:  2015-06-23       Impact factor: 4.130

6.  The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.

Authors:  Roy E Strowd; Mary Ann Knovich; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2012-12

Review 7.  Safety of bevacizumab in patients with malignant gliomas: a systematic review.

Authors:  G Simonetti; E Trevisan; A Silvani; P Gaviani; A Botturi; E Lamperti; D Beecher; L Bertero; C Bosa; A Salmaggi
Journal:  Neurol Sci       Date:  2013-11-27       Impact factor: 3.307

8.  Thromboembolic disease in patients with high-grade glioma.

Authors:  James R Perry
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 9.  Surgical treatment of metastatic brain tumors.

Authors:  R Sawaya; B L Ligon; A K Bindal; R K Bindal; K R Hess
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

10.  Anticoagulation for noncardiac indications in neurologic patients: comparative use of non-vitamin k oral anticoagulants, low-molecular-weight heparins, and warfarin.

Authors:  Ariela L Marshall; Jean-Marie Connors
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.